Multiparametric magnetic resonance imaging is proving to be an excellent tool for detecting aggressive prostate cancers and performing targeted biopsies. Potentially, it will reduce overdetection and underdetection and optimise active surveillance and other aspects of cancer assessment and treatment.
In recent years, magnetic resonance imaging (MRI) technology has improved and MRI is now evolving to have an encouraging role in the diagnosis and management of men with prostate cancer. The ability to accurately detect prostate cancer and risk-stratify patients is central to being able to counsel men about treatment options.
Picture credit: © Skynesher/iStockphoto.com. Model used for illustrative purposes only.